Product Information

METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0502 per EA under NDC 49483062450. Its NADAC has been published 511 times since Feb 8, 2017.

FDA first approved this application on Apr 29, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL ER 750 MG TABLET

Metformin Hydrochloride
$0.0502per EA

Strength

750 mg/1

Manufacturer

Time-Cap Labs Inc.

NDC

49483062450

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090295

FDA Approved

4/29/2016

TE Code

AB1

On Market Since

5/12/2016

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 511 times since Feb 8, 2017, and over the history we have for it it has declined 46.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0502 per EA
All-time high$0.0948 (Mar 15, 2017)
All-time low$0.0502 (Nov 18, 2026)
52-week high$0.0566
52-week low$0.0502
Median price$0.0656
Average price$0.0685
Largest weekly change+26.5% (Dec 23, 2020)
Weeks tracked511
Tracking sinceFeb 8, 2017

Price History

1W

-1.1%

1M

-4.7%

3M

-7.4%

6M

-9.2%

1Y

-7.8%

3Y

-26.0%

5Y

-41.4%

All

-46.8%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0502 per EA (NDC 49483062450), effective Nov 18, 2026.

How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 46.8%. It has been tracked across 511 weekly CMS publications since Feb 8, 2017.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?

Since Feb 8, 2017, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0502 (Nov 18, 2026) to a high of $0.0948 (Mar 15, 2017), with a median of $0.0656 per EA.

Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL ER 750 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METFORMIN HCL ER 750 MG TABLET?

METFORMIN HCL ER 750 MG TABLET (NDC 49483062450) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.